Clinical challenges of nosocomial infections caused by antibiotic-resistant pathogens in pediatrics

Related Experiment Video

Updated: Aug 24, 2026

Preparation of Zinc Oxide Nanoparticles and the Evaluation of their Antibacterial Effects
06:42

Preparation of Zinc Oxide Nanoparticles and the Evaluation of their Antibacterial Effects

Published on: September 27, 2024

Alice Pong1, John S Bradley

  • 1Division of Infectious Diseases, Children's Hospital and Health Center, San Diego, CA 92123, USA.

Seminars in Pediatric Infectious Diseases
|June 4, 2004
PubMed

Insights

Antibiotic resistance in hospital-acquired infections is a growing concern. Understanding adaptive resistance mechanisms and mobile genetic elements is crucial for treating infections caused by resistant pathogens.

Area of Science:

  • Infectious Diseases
  • Microbiology
  • Clinical Medicine

Background:

  • Antibiotic resistance in nosocomial infections presents a significant and escalating challenge in healthcare.
  • Healthcare institutions increasingly manage pediatric patients with complex medical and surgical conditions, exacerbating this issue.

Purpose of the Study:

  • To review the mechanisms of antibiotic resistance in common nosocomial pathogens.
  • To discuss the role of mobile genetic elements in the spread of resistance.
  • To outline strategies for treating infections caused by antibiotic-resistant organisms.

Main Methods:

  • Review of scientific literature on antibiotic resistance mechanisms.
  • Analysis of adaptive resistance strategies in gram-negative and gram-positive bacteria.
  • Discussion of clinical case studies and outbreak descriptions.

Main Results:

  • Adaptive resistance mechanisms enable pathogens to survive extensive antibiotic use, leading to significant infections.
  • Mobile genetic elements accelerate the dissemination of antibiotic resistance within and between bacterial species.
  • Nosocomial outbreaks caused by resistant organisms are a documented clinical reality.

Conclusions:

  • Understanding resistance mechanisms is vital for effective treatment of nosocomial infections.
  • Developing targeted therapeutic strategies is essential to combat resistant pathogens.
  • Empiric therapy must consider local resistance patterns, infection site, and likely pathogens.

More Related Videos

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria11:32

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria

Published on: February 23, 2014

Subcutaneous Infection of Methicillin Resistant Staphylococcus Aureus (MRSA)12:18

Subcutaneous Infection of Methicillin Resistant Staphylococcus Aureus (MRSA)

Published on: February 9, 2011

Related Concept Videos

Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...
Development of Antibiotic Resistance01:30

Development of Antibiotic Resistance

Antibiotic resistance is a major public health concern that arises when bacteria evolve mechanisms to withstand the effects of antibiotic treatments. This resistance can be intrinsic, acquired through genetic mutations, or transferred between bacteria via horizontal gene transfer. The development of antibiotic resistance poses significant challenges in treating bacterial infections and necessitates ongoing research to develop new therapeutic strategies.Intrinsic resistance occurs when bacterial...
Antibiotic Selection00:57

Antibiotic Selection

Overview
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...